Grace Therapeutics (GRCE) Stock Insights
GRCE$2.01+0.14 +7.49%
$32.71M
Market Cap
-1.47
P/E
1.26
Forward P/E
68
Score
Grace Therapeutics (GRCE) Stock Insights
GRCE price $2.01 +0.14 +7.49%
- Ticker
- GRCE
- Price
- $2.01
- Change
- +0.14 +7.49%
- Market cap ?
- $32.71M
- P/E ?
- -1.47
- Forward P/E ?
- 1.26
- Dividend yield ?
- 0.00%
- Beta ?
- 0.37
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 68
- Value
- 56
- Quality
- 49
- Growth
- 100
Stocklytics score rationale: value 56, quality 49, growth 100.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 309318 | 0 | 0 | 0 | 0 | 0 |
Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended…
Fair value
GRCE fair value $31.92. Price $2.01. Price is 94% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 87.55K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 16.27M. Net debt -16.98M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.15 | — | 1.00M |
| 2026-08-13 | -0.91 | -0.13 | — | 400.00K |
| 2026-06-18 | -0.07 | -0.24 | — | 900.00K |
| 2026-02-12 | -0.14 | -0.09 | — | — |
| 2025-11-13 | -0.08 | -0.12 | — | — |
| 2025-08-12 | -0.21 | -0.22 | — | — |
| 2025-06-23 | 0.10 | -0.20 | — | — |
| 2025-02-13 | -0.26 | -0.24 | — | — |
| 2024-11-13 | -0.33 | -0.33 | — | — |
| 2024-08-09 | -0.24 | -0.27 | — | — |
| 2024-06-21 | -0.17 | -0.35 | — | — |
| 2024-02-12 | -0.21 | -0.23 | — | — |
| 2023-11-13 | -0.43 | -0.26 | — | — |
| 2023-08-11 | -0.54 | -0.28 | — | — |
| 2023-06-23 | -3.90 | -0.84 | — | — |
| 2023-02-14 | -0.54 | -0.74 | — | — |
| 2022-11-14 | -0.66 | — | — | — |
| 2022-08-11 | -0.79 | — | — | — |
| 2022-06-21 | -0.72 | — | — | — |
| 2022-02-14 | -0.65 | — | — | — |
| 2021-11-10 | 0.23 | — | — | — |
| 2021-08-12 | -1.10 | — | — | — |
| 2021-06-22 | -3.91 | — | 181.49K | — |
| 2021-02-09 | -2.52 | — | 132.06K | — |
| 2020-11-16 | -5.50 | — | — | — |
| 2020-08-13 | -4.54 | — | — | — |
| 2020-06-30 | 18.86 | — | — | — |
| 2019-06-26 | -9.46 | — | — | — |
| 2018-06-29 | -17.67 | — | — | — |
| 2016-05-31 | -6.18 | — | 14.90K | — |
| 2015-06-17 | -8.56 | — | 135.60K | — |
| 2014-06-06 | -9.60 | — | 166.75K | — |
| 2013-05-30 | -11.58 | — | 27.58K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Opaleye Management Inc. | Buy | 66.41K | $1.77 | 117.41K |
| 2026-10-22 | Opaleye Management Inc. | Buy | 21.39K | $1.93 | 41.19K |
| 2026-10-19 | Opaleye Management Inc. | Buy | 4.26K | $1.88 | 8.00K |
| 2026-10-16 | Opaleye Management Inc. | Buy | 36.35K | $1.89 | 68.76K |
| 2026-10-15 | Opaleye Management Inc. | Buy | 23.48K | $1.95 | 45.69K |
| 2026-10-14 | Opaleye Management Inc. | Buy | 11.23K | $1.93 | 21.73K |
| 2026-10-12 | Opaleye Management Inc. | Buy | 7.21K | $2.02 | 14.57K |
| 2026-10-09 | Opaleye Management Inc. | Buy | 5.34K | $2.04 | 10.92K |
| 2026-10-08 | Opaleye Management Inc. | Buy | 2.08K | $2.02 | 4.19K |
| 2026-10-05 | Opaleye Management Inc. | Buy | 1.69K | $2.06 | 3.49K |
| 2026-10-02 | Opaleye Management Inc. | Buy | 20.00K | $2.07 | 41.37K |
| 2026-10-01 | Opaleye Management Inc. | Buy | 38.80K | $2.04 | 78.96K |
| 2026-09-29 | Opaleye Management Inc. | Buy | 7.85K | $2.09 | 16.40K |
| 2026-09-23 | Opaleye Management Inc. | Buy | 5.32K | $2.10 | 11.17K |
| 2026-09-23 | Opaleye Management Inc. | Buy | 5.32K | $2.10 | 11.17K |
| 2026-09-21 | Opaleye Management Inc. | Buy | 9.77K | $2.10 | 20.52K |
| 2026-09-21 | Opaleye Management Inc. | Buy | 9.77K | $2.10 | 20.52K |
| 2026-09-17 | NEUGEBOREN EDWARD | Buy | 12.20K | $2.13 | 25.99K |
| 2026-09-17 | DAVIS A BRIAN | Buy | 0 | $2.13 | 0 |
| 2026-09-17 | Kavuru Vimal | Buy | 12.20K | $2.13 | 25.99K |
| 2026-09-17 | Kottayil George | Buy | 12.20K | $2.13 | 25.99K |
| 2026-09-09 | Opaleye Management Inc. | Buy | 5.84K | $2.09 | 12.20K |
| 2026-09-09 | Kohli Prashant | Buy | 100.00K | $2.14 | 214.00K |
| 2026-09-08 | Opaleye Management Inc. | Buy | 9.39K | $2.10 | 19.70K |
| 2026-08-28 | Kumar Amresh | Buy | 35.76K | $2.12 | 75.81K |
| 2026-08-28 | Kohli Prashant | Buy | 267.16K | $2.12 | 566.38K |
| 2026-08-28 | Macdonald R. Loch | Buy | 54.69K | $2.12 | 115.94K |
| 2026-08-28 | DelAversano Robert J | Buy | 33.66K | $2.12 | 71.36K |
| 2026-08-14 | Opaleye Management Inc. | Buy | 11.61K | $2.09 | 24.21K |
| 2026-01-08 | Kavuru Vimal | Buy | 10.00K | $3.80 | 38.00K |
| 2026-01-08 | Kottayil George | Buy | 10.00K | $3.80 | 38.00K |
| 2026-01-08 | NEUGEBOREN EDWARD | Buy | 10.00K | $3.80 | 38.00K |
| 2026-01-08 | DAVIS A BRIAN | Buy | 10.00K | $3.80 | 38.00K |
| 2025-05-09 | Kottayil George | Buy | 10.00K | $2.72 | 27.20K |
| 2025-05-09 | NEUGEBOREN EDWARD | Buy | 10.00K | $2.72 | 27.20K |
| 2025-05-09 | DAVIS A BRIAN | Buy | 10.00K | $2.72 | 27.20K |
| 2025-05-09 | Kavuru Vimal | Buy | 10.00K | $2.72 | 27.20K |
| 2025-04-14 | Kumar Amresh | Buy | 30.00K | $2.08 | 62.40K |
| 2025-04-14 | Macdonald R. Loch | Buy | 40.00K | $2.08 | 83.20K |
| 2025-04-14 | DelAversano Robert J | Buy | 20.13K | $2.08 | 41.87K |
| 2025-04-14 | Kohli Prashant | Buy | 225.40K | $2.08 | 468.83K |
| 2025-04-14 | D'Andrea Carrie | Buy | 30.00K | $2.08 | 62.40K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 37, holders +1 vs prior quarter. Ownership 24.00%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CERITY PARTNERS LLC | 849.05K | 0 | 0.00% | 1.93M |
| EVERSEPT PARTNERS, LP | 772.90K | 16.30K | +2.15% | 1.75M |
| BANK OF AMERICA CORP /DE/ | 494.70K | -25 | -0.01% | 1.12M |
| VANGUARD CAPITAL MANAGEMENT LLC | 411.71K | 10.06K | +2.50% | 934.59K |
| CITADEL ADVISORS LLC | 349.74K | 251.00K | +254.20% | 793.91K |
| MAVEN SECURITIES LTD | 200.00K | 200.00K | New | 454.00K |
| BIRCHVIEW CAPITAL, LP | 120.00K | 70.00K | +140.00% | 272.40K |
| CANTOR FITZGERALD, L. P. | 100.00K | 100.00K | New | 227.00K |
| TWO SIGMA INVESTMENTS, LP | 96.89K | 96.89K | New | 219.94K |
| JANE STREET GROUP, LLC | 89.44K | -77.66K | -46.47% | 203.03K |
| JANE STREET GROUP, LLC | 72.10K | -95.00K | -56.85% | 163.67K |
| XTX TOPCO LTD | 71.67K | 8.57K | +13.59% | 162.69K |
| HRT FINANCIAL LP | 62.69K | 62.69K | New | 142.00K |
| CITADEL ADVISORS LLC | 52.50K | -46.24K | -46.83% | 119.17K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 49.58K | -1.02K | -2.02% | 112.54K |
| BLACKROCK, INC. | 37.53K | 37.53K | New | 85.20K |
| STONEPINE CAPITAL MANAGEMENT, LLC | 294.55K | 294.55K | New | 62.12K |
| RANGELEY CAPITAL, LLC | 26.00K | 26.00K | New | 59.02K |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 23.00K | 10.00K | +76.92% | 52.21K |
| UBS GROUP AG | 16.78K | -9.52K | -36.21% | 38.08K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.00K | -37.60K | -74.31% | 29.51K |
| STRATOS INVESTMENT MANAGEMENT, LLC | 11.16K | 11.16K | New | 25.33K |
| BNP PARIBAS FINANCIAL MARKETS | 10.50K | 3.40K | +47.89% | 23.84K |
| SCIENTECH RESEARCH LLC | 10.18K | 10.18K | New | 23.12K |
| VIRTU FINANCIAL LLC | 10.17K | 10.17K | New | 23.00K |
Insights · Dividends · Forecast · Financials · Learn